| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
AML in 2017: Advances in clinical practice
|
Rowe, Jacob M.
|
|
2017
|
30 |
4 |
p. 283-286
4 p.
|
artikel
|
| 2 |
Autologous hematopoietic cell transplantation for adult acute myeloid leukemia: An obsolete or resurfacing concept?
|
Lazarus, Hillard M.
|
|
2017
|
30 |
4 |
p. 327-332
6 p.
|
artikel
|
| 3 |
Cytokine release syndrome: Who is at risk and how to treat
|
Frey, Noelle
|
|
2017
|
30 |
4 |
p. 336-340
5 p.
|
artikel
|
| 4 |
Do cytogenetics affect the post-remission strategy for older patients with AML in CR1?
|
Foran, James M.
|
|
2017
|
30 |
4 |
p. 306-311
6 p.
|
artikel
|
| 5 |
Editorial Board / Aims & Scope
|
|
|
2017
|
30 |
4 |
p. iii-
1 p.
|
artikel
|
| 6 |
Familial myelodysplastic syndrome/acute myeloid leukemia
|
Churpek, Jane E.
|
|
2017
|
30 |
4 |
p. 287-289
3 p.
|
artikel
|
| 7 |
How can one optimize induction therapy in AML?
|
Luger, Selina M.
|
|
2017
|
30 |
4 |
p. 301-305
5 p.
|
artikel
|
| 8 |
Impact of allogeneic hematopoietic cell transplantation on the outcome of older patients with acute myeloid leukemia
|
Appelbaum, Frederick R.
|
|
2017
|
30 |
4 |
p. 320-326
7 p.
|
artikel
|
| 9 |
Index
|
|
|
2017
|
30 |
4 |
p. I-
1 p.
|
artikel
|
| 10 |
Intracellular protein degradation: From a vague idea thru the lysosome and the ubiquitin-proteasome system and onto human diseases and drug targeting
|
Ciechanover, Aaron
|
|
2017
|
30 |
4 |
p. 341-355
15 p.
|
artikel
|
| 11 |
Mutational complexity in myelodysplasia
|
Lindsley, R. Coleman
|
|
2017
|
30 |
4 |
p. 290-294
5 p.
|
artikel
|
| 12 |
Relapsed acute lymphoblastic leukemia: Is it crucial to achieve molecular remission prior to transplant?
|
Eapen, Mary
|
|
2017
|
30 |
4 |
p. 317-319
3 p.
|
artikel
|
| 13 |
The evolving role of genomic testing in assessing prognosis of patients with myelodysplastic syndromes
|
Steensma, David P.
|
|
2017
|
30 |
4 |
p. 295-300
6 p.
|
artikel
|
| 14 |
Which factors influence the development of GVHD in HLA-matched or mismatched transplants?
|
Petersdorf, Effie W.
|
|
2017
|
30 |
4 |
p. 333-335
3 p.
|
artikel
|
| 15 |
Which new agents will be incorporated into frontline therapy in acute myeloid leukemia?
|
Stone, Richard M.
|
|
2017
|
30 |
4 |
p. 312-316
5 p.
|
artikel
|
Tijdschrift beschrijving